- Sinoveda News Release
November 9ProFlexa® for Arthritis
November 7How Traditional Methods Can Make Modern Medical Magic
November 5Why You Should Consider A Calcium Supplement
November 2How to Spot Early Signs of Arthritis
October 29How to treat minor symptoms of Osteoporosis
October 26How to Treat Eczema Flare Ups
October 24The Natural Health Product Development Process: How to Know Your Remedy is Safe
October 23How to Protect Yourself from Bone Density Loss
October 9Treating Seasonal Eczema Flare Ups
October 3EffectiCal®: Protecting Your Bone Health Against Osteoporosis
September 10Why Take a Calcium Supplement
September 4Proflexa®‘s Traditional TCM Influence
August 28How to Deal with Eczema Flare Ups
August 28Treating Eczema Naturally
August 21Sinoveda’s Patented Pharmaceutical Platform Technology
August 16Treating Osteoporosis and Bone Loss Naturally
August 10Treating Arthritis Naturally
Biotechnology in Hong Kong: Volume II Publication
August 17, 2015
SinoVeda Canada Inc. is pleased to announce the forthcoming publication of Biotechnology in Hong Kong: Volume II, which includes a chapter written by company president Dr. Yun Tam, “Transforming Traditional Chinese Medicine to Mainstream Pharmaceuticals.” This chapter describes SinoVeda’s patented Pharmaceutical Platform Technology (PPT)®, the science supporting its efficacy, and its possible commercial applications.
Retirement of Paul H. Braconnier
October 23, 2014
SinoVeda Canada today announced the retirement of Paul H. Braconnier from our Board of Directors. Mr. Braconnier has been a valuable member of our team and we wish him well in his active retirement. SinoVeda CFO Al Gourley has been appointed to the Board in his stead.
Positive clinical results for EffectiCal® compared to Caltrate®
May 21, 2014
EDMONTON, Alberta (May 21, 2014 ): SinoVeda Canada Inc. today announces positive clinical results for EffectiCal® from its 24-week double-blind, randomized comparative clinical trial in post-menopausal women.
The results showed that EffectiCal®, a supplement containing 300mg of calcium, was equally as effective as Caltrate® (600mg calcium) and vitamin D3 in measurements of bone formation and bone resorption. Additionally, subjects in this study who received EffectiCal® had significantly fewer gastrointestinal side effects than those taking Caltrate®.